Another thesis successfully defended 👏
Congratulations to Aina Rill (@eli_mereu's lab) with her work on "Mapping Inflammation and T cell Dynamics with Single-Cell Genomics" 🧬💻
Well done, new doctor!👩🔬🎓
It took 3 years, 4 rounds of reviews, 96 VISIUM samples, 10 cancer types, and 1 clinical trial, but it's finally out:
The spatial landscape of Cancer Hallmarks reveals patterns of tumor ecological dynamics and drug sensitivity
Here's what's new 👇
https://t.co/WMCyTWhVOX
🏆Congratulations to @rill_aina for winning a Molecular Oncology prize at the 2024 @CarrerasIJC Symposium, with her poster "Integrative single-cell multi-omics of CD19-CARpos and CARneg T cells suggest drivers of immunotherapy response in B-cell neoplasias"👏
Very honored to have received one of the Molecular Oncology Poster Session Awards last week from #IJCSymposium “Updates on Genetics and Epigenetics of Haematological Malignancies: From Knowledge to Applications” at @CarrerasIJC ✨
So i'm very happy to say that my very talented honours student has reimplemented the entire trajectory workflow in R, intersecting with @theHumanBorch's scRepetoire! Code is now live https://t.co/DUHdzq0V7P but lacking vignette; will be up shortly!)
Check out how we found intrinsic factors of CAR-T cells that may play a major role on its clinical success by single-cel multiomics!! 🧬💻💖
Paper available in Cell Reports Medicine:
https://t.co/zoo9DEZwQb
🚨Researchers from the @Menendez_Lab and @eli_mereu Lab, @MerGuMu@trincadojl@rill_aina describe at @CellRepMed the molecular features making a CAR-T cells infusion successful 💪
Read the news piece at 👇
https://t.co/ozZZg3K79X
Results show objective features in the infusion product may predict future therapeutic success, advocating for a more precise quality control.
Also, characteristics of the CAR-T expansion within the patient are related to efficacy and could be used as early warning.
Thanks to funders 🫶 @contracancerINV@FundlaCaixa@unoentrecienmil@fcarreras
🚀 New research alert! Dive into the single-cell multi-omics of CD19-CAR+ and CAR- T cells! A promising step in #CARTcell therapy for better outcomes! Led by @MerGuMu, @rill_aina & @trincadojl from @Menendez_Lab and my lab! Enjoy! https://t.co/O1yfWBAfoE
STAMP is OUT!
Sequencing-free #singlecell RNA and Protein profiling.
Game-changing approach for scalable and cost-efficient analysis of single cells.
The future starts today!
Amazing @LGMartelotto @DrJasPlummer
https://t.co/tgsIvTtpBo
Brilliant �� #YoungResearchers Seminar yesterday with Aina Rill, from @eli_mereu’s lab!
We have learnt more about her project "Integrative #SingleCell multi-omics of CD19-CARpos and CARneg T cells suggest drivers of immunotherapy response in B-cell neoplasias". Great work! 👏
📢Our lab at the @CarrerasIJC is looking for candidates for the competitive PhD INPhINIT incoming fellowship from La Caixa Foundation. We work on the application of #singlecell genomics and ML to improve cell-based immunotherapy in Myeloma and others B-cell neoplasms. Plz RT!🔁
Our multimodal model to combine TCR sequences with scRNA-seq is finally out. The most interesting part for me was observing a clear case where the combination of TCR sequence and cell state (RNA) preserved both clonotype and cell type information, leading to a more holistic cell representation that captures phenotype and functionality. We also decompose the contribution and importance of each modality. This was a really fun project spearheaded by @DrostFelix, whose amazing perseverance during a long review period, and collaboration with @schubert_benni and other fantastic collaborators, made it possible.
Read the paper :https://t.co/UtrYcb5EyY
Really glad to see our work published in @Nature@CommsBio: https://t.co/46XqPNW5yi.
This analysis of 39 fragment screening experiments sets the scene for our future work on function prediction for ligand sites across the @PDBeurope. @gjbarton@bartongrp@stuartmac44@CallumMIves